30.06.2020 · Drug Discovery Today: Disease Models is discontinued as of 2021… Elsevier stands against racism and discrimination and fully supports the joint commitment for action in inclusion and diversity in publishing. In partnership with the communities we serve; we redouble our deep commitment to inclusion and diversity within our editorial, author and reviewer networks.
Nov 16, 2021 · Drug Discovery Today: Disease Models IS is increased by a factor of 0.43 and approximate percentage change is 86% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles ...
Read the latest articles of Drug Discovery Today: Disease Models at ScienceDirect.com, Elsevier's leading platform of peer-reviewed scholarly literature.
Drug Discovery Today: Disease Models Vols. 19, 2016 Editors-in-Chief Jan Tornell – AstraZeneca, Sweden Andrew McCulloch – University of California, San Diego, USA Contents DOI: 10.1016/S1740-6757(17)30031-2 www.drugdiscoverytoday.com i DRUG DISCOVERYTODAY DISEASE MODELS
Read the latest articles of Drug Discovery Today: Disease Models at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Scope Drug Discovery Today: Disease Models is an integral part of the Drug Discovery Today journal suite. Disease Models Special Sections are a one-stop resource on in vitro, in vivo and in silico- italicized models of human disease with an emphasis on etiology, pathogenesis and molecular mechanisms.
Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and ...
Read the latest articles of Drug Discovery Today: Disease Models at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Drug Discovery Today: Disease Models is an integral part of the Drug Discovery Today journal suite. Disease Models Special Sections are a one-stop resource on in vitro, in vivo and in silico-italicized models of human disease with an emphasis on etiology, pathogenesis and molecular mechanisms.
Drug Discovery Today: Disease Models. View Articles. Track your paper. Track accepted paper; Special Issues. Special section on Skin disease and Women's health. 2020-24 Volume 32, Part B. Neurovirology. Donatella Moschettini, Donatella Donati, Steven Jacobson 2020-23 …
Read the latest articles of Drug Discovery Today: Disease Models at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Read the latest articles of Drug Discovery Today: Disease Models at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
In 2005, there were 14 personalized medicines on the market, and today there are ... Modeling in Animal-Based Research in Support of Precision Medicine: ...
Drug Discovery Today Disease Models | The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific ...
16.11.2021 · Drug Discovery Today: Disease Models has an h-index of 26.It means 26 articles of this journal have more than 26 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h …
It is an effective strategy in discovering or developing drug molecules with ... and cell/organism-based screens in in vitro and/or in vivo disease models ...